Clarification of entry criteria for the European Organization for Research and Treatment of Cancer H5-favorable trial of early-stage Hodgkin's disease [3]

G. M. Rasp, M. G. Haddock, J. A. Martenson, P. Carde

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Clarification of entry criteria for the European Organization for Research and Treatment of Cancer H5-favorable trial of early-stage Hodgkin's disease [3]'. Together they form a unique fingerprint.